Utilizzo di idrato di cloralio in un caso di stato di male farmacoresistente

Translated title of the contribution: Use of chloral hydrate in a case of pharmacoresistant status epilepticus

R. Marino, A. Ferrari, R. Di Comite, E. Cristiani, O. Monetti, E. Silvestri, P. Tortori Donati, M. Di Rocco, P. Tuo, L. Nahum, R. Gaggero

Research output: Contribution to journalArticlepeer-review

Abstract

In the treatment of status epileptcus (SE), first line drugs are benzodiazepines and others as PHT, that are successful in 80% of the cases. In a pharmacoresistant case of SE the only effective drug was chloral hydrate (IC), usually employed as sedative hypnotic. A girl 13 yrs old presented a severe SE with motor partial seizures secondarily generalised, that continued for more than 30 days despite several first choice treatments. In this period, MRI showed a diffuse cortical laminar necrosis, secondary to the hypoxic damage. No cause of this condition was demonstrated. IC oral administration was followed by a reduction of the seizures > 90% for a period of 6 months.

Translated title of the contributionUse of chloral hydrate in a case of pharmacoresistant status epilepticus
Original languageItalian
Pages (from-to)405-407
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number118
Publication statusPublished - Oct 2002

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Use of chloral hydrate in a case of pharmacoresistant status epilepticus'. Together they form a unique fingerprint.

Cite this